Search details
1.
Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation.
Haematologica
; 108(3): 797-810, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36226498
2.
Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients.
Blood
; 122(14): 2412-24, 2013 Oct 03.
Article
in English
| MEDLINE | ID: mdl-23940282
3.
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.
Blood
; 119(11): 2590-4, 2012 Mar 15.
Article
in English
| MEDLINE | ID: mdl-22279054
4.
Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy.
Blood
; 125(14): 2306-9, 2015 Apr 02.
Article
in English
| MEDLINE | ID: mdl-25838279
5.
An Unbiased CRISPR-Cas9 Screening Method for the Identification of Positive and Negative Regulatory Proteins of Cell Adhesion.
Bio Protoc
; 12(21)2022 Nov 05.
Article
in English
| MEDLINE | ID: mdl-36505024
6.
A loss-of-adhesion CRISPR-Cas9 screening platform to identify cell adhesion-regulatory proteins and signaling pathways.
Nat Commun
; 13(1): 2136, 2022 04 19.
Article
in English
| MEDLINE | ID: mdl-35440579
7.
Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia.
Haematologica
; 101(3): e111-5, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26635033
8.
N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.
Haematologica
; 96(11): 1653-61, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21828122
Results
1 -
8
de 8
1
Next >
>>